Additionally, the health IT company’s fiscal year revenue totaled $179 billion, up 30 percent from the $137.4 billion the previous year.
McKesson’s reported profit for the last quarter was $132 million, a 64 percent decrease from $370 million during the same time last year, according to a Wall Street Journal report, which suggests part of the decline is due to a $150 million settlement with the U.S. government for charges related to order reporting practices for controlled substances.
More articles on health IT:
Criminal attacks No. 1 cause of healthcare data breaches: 5 things to know
Allscripts stock leaps 5.7%: 3 things to know
78M consumers worldwide to use home health technologies by 2020
